We found that overexpression of AP-2α significantly increased glioma cell apoptosis and synergistically enhanced the cytotoxicity of TMZ, which was in concomitant with decreased expression of Survivin, a critical drug resistance regulator, and the downstream gene MDR-1. The gene discussed is ABCB1; the disease is glioma.